Background Several studies have revealed that N6-methyladenosine (m6A) regulation is
involved in various biological processes and cancer progression. Nevertheless, the potential …

Background: Pancreatic adenocarcinoma (PAAD) is a rare cancer with a poor prognosis. N6-
methyladenosine (m6A) is the most common mRNA modification. However, little is known …

Recent studies have shown that RNA N6-methyladenosine (m6A) modification plays an
important part in tumorigenesis and immune-related biological processes. However, the …

Objective: N6-methyladenosine (m6A) modification may modulate various biological
processes. Nonetheless, clinical implications of m6A modification in pancreatic cancer are …

Pancreatic cancer (PC) is a malignant tumor of the digestive system that has a bad
prognosis. N6‐methyladenosine (m6A) is involved in a wide variety of biological activities …

Background Pancreatic adenocarcinoma (PAAD) is among the most lethal diseases and has
a dismal prognosis; however, efficient treatment is currently limited. Several studies have …

Background The relationship between N6-methyladenosine (m 6 A) RNA methylation
regulators and the tumor immune microenvironment has been extensively studied …

Background Increasing studies have demonstrated the biological function of RNA N6-
methyladenosine (m6A) modifications in tumorigenesis. However, the potential role of m6A …

Background: There is increasing evidence of the epigenetic regulation of the immune
response in cancer. However, the specific functions and mechanisms of RNA N6 …

Pancreatic cancer (PAAD) is one of the most malignant cancers and immune
microenvironment has been proved to be involved in pathogenesis of PAAD. m6A …